Related Experiment Video
Updated: Jul 10, 2026
10:20
Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
Published on: June 16, 2008
HIV-1 proviral DNA excision using an evolved recombinase.
Indrani Sarkar1, Ilona Hauber, Joachim Hauber
1Max-Planck-Institute for Molecular Cell Biology and Genetics, Pfotenhauerstrasse 108, D-01307 Dresden, Germany.
Science (New York, N.Y.)
|June 30, 2007
Summary
Scientists evolved a new enzyme to remove integrated human immunodeficiency virus type 1 (HIV-1) DNA from infected cells. This breakthrough offers potential for future HIV therapies targeting the provirus.
Area of Science:
- Molecular Biology
- Virology
- Biotechnology
Background:
- Human immunodeficiency virus type 1 (HIV-1) establishes lifelong infections by integrating its genetic material into the host cell genome as a provirus.
- Current antiretroviral therapies primarily target viral enzymes or virus entry, leaving the integrated provirus untouched.
- There is a critical need for strategies that can eliminate the latent viral reservoir.
Purpose of the Study:
- To evolve a novel recombinase enzyme capable of specifically recognizing and excising integrated HIV-1 proviral DNA.
- To assess the efficiency of the engineered recombinase in removing proviral DNA from infected cells.
Main Methods:
- Utilized substrate-linked protein evolution to develop a tailored recombinase.
- Designed the recombinase to recognize a specific asymmetric sequence within the HIV-1 long terminal repeat (LTR).
- Tested the recombinase's ability to excise integrated HIV-1 proviral DNA from infected cellular genomes.
Main Results:
- Successfully evolved a recombinase with high specificity for an asymmetric sequence within the HIV-1 LTR.
- Demonstrated efficient excision of integrated HIV proviral DNA from the host cell genome.
- The engineered recombinase effectively targeted and removed the proviral DNA in infected cells.
Conclusions:
- The developed tailored recombinase shows promise for targeting and excising integrated HIV-1 proviral DNA.
- This approach represents a potential new strategy for future antiretroviral therapies aimed at viral eradication.
- Further development is needed for potential clinical applications, but the technology holds significant therapeutic potential.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:28CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...